Import of Biological Specimens into India
A Biological specimen is a pharmaceutical product prepared by utilizing living cells and tissues to prevent, diagnose, or treat diseases. […]
Biologics
Gene Therapy Applications, Regulations & Guidance
The applications of gene therapy represent a revolutionary advancement in medicine, providing hope for curing diseases instead of relying on
Biologics and Biosimilars Regulations and Registration in Mexico (COFEPRIS)
Mexico is the second-largest drug market in Latin America, after Brazil. With a compound annual growth rate (CAGR) of 38.7%,
Biologics and Biosimilars Regulation and Registration in India (CDSCO)
The size of the Indian biosimilars market, which was anticipated to be worth $349 million in 2022, is expected to
Nano-Biotechnology: Tiny Innovations With Big Impact On Biologics
Nano-biotechnology is an interdisciplinary field that combines nanotechnology and biotechnology to manipulate and study biological systems at the nanoscale. The
Biologics in Autoimmune Diseases: A New Hope for Patients
Autoimmune diseases are complex and diverse, affecting millions of people globally with varying degrees of severity and symptoms. There are
Biosimilar Product Development: Regulatory Challenges & Key Insights
In this era where the demand for affordable healthcare is increasing every day, biosimilars that are replacements for biologics have
Bioconjugates: Combining the Best of Biologics and Small Molecules
Bioconjugates are molecules formed by chemically linking two or more molecules, typically involving a biological molecule like a protein, enzyme,
Biosimilars vs. Generics: Key Differences and Market Implications
In pharmaceuticals, biosimilars and generics are two important categories that often come up in discussions about drug affordability and accessibility.